Oaktree Acquisition Corp. III Life Sciences (OACC) Research
Oaktree Acquisition Corp. III Life Sciences is dedicated to completing a strategic business combination, such as a merger, asset acquisition, share purchase, reorganization, or similar transaction, with one or more companies. The firm's focus is on identifying and acquiring entities within the biopharmaceutical, medical device, diagnostics, and specialized healthcare services industries located across North America and Europe. This company was formed in 2024 and is headquartered in Los Angeles, California.
Market snapshot
- Symbol
- OACC
- Price
- $10.65
- Day change
- 0.00%
- Market cap
- $261.8M
- P/E ratio
- 29.11x
- 52-week range
- 10.3-10.736
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
- Artius II Acquisition Inc. Class A Ordinary Shares (AACB)
- Cartesian Growth Corporation III (CGCT)
- Copley Acquisition Corp (COPL)
- FACT II Acquisition Corp (FACT)
- M3-Brigade Acquisition V Corp. Class A Ordinary shares (MBAV)
- Mountain Lake Acquisition Corp. (MLAC)
- Perimeter Acquisition Corp. I Class A Ordinary Shares (PMTR)
- Rithm Acquisition Corp. (RAC)
Recent insider activity
- Martinez George Arthur — trade (0 shares) on 2025-10-29
- BERRY DAVID A — trade (0 shares) on 2025-10-17
- Sweeney Thomas — trade (0 shares) on 2025-06-03
- Oaktree Acquisition Holdings III LS, LLC — J-Other (231492 shares) on 2024-10-30
- Oaktree Acquisition Holdings III LS, LLC — C-Conversion (33981 shares) on 2024-10-30
Open Oaktree Acquisition Corp. III Life Sciences (OACC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.